Zhongchao Inc. Pronounces its New Technique Extension Specializing in the Oncology and Different Main Illness Administration

Zhongchao Inc. Pronounces its New Technique Extension Specializing in the Oncology and Different Main Illness Administration

SHANGHAI, Sept 1, 2022 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Firm”), an web know-how firm providing healthcare professionals the net healthcare info, skilled coaching and academic companies platform and affected person administration service, at this time introduced its newly added enterprise part of  oncology and different main illness administration which is part of its improvement technique to increase its enterprise mannequin from “Medical-Pharmaceutical” to  “Medical-Pharmaceutical-Affected person.” Using its gathered experiences in medical training and innovation, and in depth sources with medical professionals and prescribed drugs, Zhongchao is effectively positioned to grow to be a platform that gives sufferers with main illness administration companies.

The Firm has applied a number of strategic initiatives to remodel to the brand new “Medical-Pharmaceutical-Affected person” mannequin. In 2021, Zhongchao launched affected person administration enterprise specializing in the skilled discipline of tumor and uncommon illness via its subsidiary Shanghai Zhongxin Medical Know-how Co., Ltd. (“Zhongxin”), which was the necessary first step of the rework. The technique to increase enterprise mannequin was pushed by the elevated calls for of “patient-oriented” healthcare in China. Administration have been intently observing and monitoring such service mannequin that’s to offer medical companies and illness administration tailor-made to particular person affected person and permit affected person to actively provoke and take part in well being administration and illness therapy since its look in 2021. It’s value to say that the Firm’s self-developed affected person administration system efficiently improved Period of Remedy (“DOT”) by 40.4% for liver most cancers sufferers, contributing to the utmost effectivity of medication, profitable therapy and longer affected person survival phrases, as in comparison with sufferers with out utilizing the administration system, primarily based on the information collected by the Firm throughout a interval from November 2017 to September 2021. In consequence, the Firm plans to proceed the event of affected person administration companies via Zhongxin.

As of now, Zhongxin gives complete illness training and administration companies for tumor sufferers receiving therapy. Via companies reminiscent of drug aids, illness follow-up visits, medicine administration, and most cancers training promotion, Zhongxin helps tumor sufferers cut back the financial burden of therapy and promote the completion the therapy course of, leading to the perfect therapy impact and enchancment the standard of life for the sufferers. As of now, greater than lots of of thousand oncology Sufferers have used both the applying developed by Zhongxin or WeChat community service platform to attach sufferers with Zhongxin’s hotline middle and repair commissioner system and acquired illness administration help.

Weiguang Yang, Chairman and Chief Govt Officer of Zhongchao, commented, “As a digital platform for medical training in China, Zhongchao continues to offer scientific and dependable medical info to sufferers and healthcare professionals. We’re dedicated to driving digital innovation in healthcare and affected person companies, and steadily extending our enterprise mannequin to “Medical-Pharmaceutical-Affected person ” for oncology and different main illness administration companies. We consider that our new enterprise mannequin will allow simpler therapy programs for particular person well-being, improved affected person expertise, optimum allocation of sources and convey extra values to our shareholders going ahead.”

About Zhongchao Inc.

Zhongchao Inc. is an offshore holding firm integrated within the Cayman Islands. It conducts operations in China via the contractual preparations between its wholly owned subsidiary and PRC working entities. The PRC working entities present on-line healthcare info, skilled coaching and academic companies to healthcare professionals underneath their “MDMOOC” platform (www.mdmooc.org), supply affected person administration service on the skilled discipline of tumor and uncommon ailments, and function an internet info platform, Sunshine Well being Boards, to normal public. Extra details about the Firm could be discovered at its investor relations web site at http://izcmd.com.

Protected Harbor Assertion

This press launch incorporates forward-looking statements as outlined by the Personal Securities Litigation Reform Act of 1995. Ahead-looking statements embody statements regarding plans, aims, objectives, methods, future occasions or efficiency, and underlying assumptions and different statements which can be apart from statements of historic information. When the Firm makes use of phrases reminiscent of “could,” “will,” “intend,” “ought to,” “consider,” “anticipate,” “anticipate,” “venture,” “estimate” or related expressions that don’t relate solely to historic issues, it’s making forward-looking statements. Ahead-looking statements aren’t ensures of future efficiency and contain dangers and uncertainties which will trigger the precise outcomes to vary materially from the Firm’s expectations mentioned within the forward-looking statements. These statements are topic to uncertainties and dangers together with, however not restricted to, the next:  the Firm’s objectives and techniques; the Firm’s future enterprise improvement; product and repair demand and acceptance; modifications in know-how; financial circumstances; the expansion of the skilled coaching and academic companies market in China and the opposite worldwide markets the Firm plans to serve; status and model; the impression of competitors and pricing; authorities rules; fluctuations generally financial and enterprise circumstances in China and the worldwide markets the Firm plans to serve and assumptions underlying or associated to any of the foregoing and different dangers contained in reviews filed by the Firm with the SEC, the size and severity of the current coronavirus outbreak, together with its impacts throughout our enterprise and operations.  For these causes, amongst others, buyers are cautioned to not place undue reliance upon any forward-looking statements on this press launch. Extra elements are mentioned within the Firm’s filings with the SEC, which can be found for assessment at www.sec.gov. The Firm undertakes no obligation to publicly revise these ahead–trying statements to replicate occasions or circumstances that come up after the date hereof.

For extra info, please contact:

On the Firm: Pei Xu, CFO
Electronic mail: xupei@mdmooc.org  
Telephone: +86 21-3220-5987

Investor Relations: Sherry Zheng  
Weitian Group LLC
Electronic mail: shunyu.zheng@weitian-ir.com  
Telephone: +1 718-213-7386

Cision View unique content material:https://www.prnewswire.com/news-releases/zhongchao-inc-announces-its-new-strategy-extension-focusing-on-the-oncology-and-other-major-disease-management-301615964.html

SOURCE Zhongchao Inc.